Scope of the Study
A bone graft is a surgical procedure that is used to fix bones or joints that were damaged by trauma, and it is also used to replace bone that is missing to provide structural stability around the body, including the jawbone. Bone allografts is the tissue that is transplanted from one person to another. They typically come from a donor, or cadaver bone, it is safely ready to use, and available in large amounts. The benefits of allograft over the autografts is required one less procedure which must first be taken from the patient and the Surgical time is minimized and the recovery can be quicker. The allograft comes from a reputable and reliable tissue bank. According to the NCBI, Over 200,000 cases involving allografts are used per year in the US.5 The lack of donor site morbidity, general success of results, and decreased surgical times make allograft a popular alternative to the autologous bone graft.
The market study is being classified by Type (Fresh or fresh-frozen bone., Freeze-dried bone allograft (FDBA) and Demineralized freeze-dried bone allograft (DFDBA)), by Application (Spine Fusion, Dental grafting, Bone Trauma and Other) and major geographies with country level break-up.
Zimmer Biomet (United States), Arthrex(United States), B. Braun (Germany), DePuy Synthes Companies(United States), Wright Medical Group(Netherlands), Geistlich Pharma AG (Switzerland and Xtant Medical(United States) are some of the key players profiled in the study.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Bone Allografts market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Bone Allografts market by Type, Application and Region.
On the basis of geography, the market of Bone Allografts has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Incidences Of Musculoskeletal Disorders
- The growing clinical requirement for the bone grafting procedure
- Growing prevalence of orthopedic disorders such as arthritis.
- Rising demand for orthopedic procedures among the geriatric population
- The emergence of Allografts Techniques
- High cost Associated With the Treatment
- The Advancement in the technologies and the shift from autograft to allograft innovations of biocompatible synthetic bone grafts is boosting the growth opportunities of the market
- Risk of disease transmission from donor to recipient
Market Leaders and their expansionary development strategies
For instance in July 2020 medtronics Ireland based company has announced their acuqistion with medicrea. With this merger acquisitions Medtronic Will Become the First Company to Offer an Integrated Solution such as Artificial Intelligence-Driven Surgical Planning, Personalized Spinal Implants and Robotic Assisted Surgery.this will helps and strengthen Medtronic’s position as a global innovator in permiting technologies and solutions for spine surgery.
"As per FDA, Docket No. 2004D-0178 The Food and Drug Administration (FDA) is announcing the availability of the guidance entitled “Class II Special Controls Guidance Document: Dental Bone Grafting Material Devices.” This guidance document describes a means by which class II dental bone grafting material devices may comply with the requirement of special controls."
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Bone Allografts Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase